From Yahoo Finance: 2025-05-29 22:56:00

Revelation Biosciences, Inc. (NASDAQ:REVB) successfully closed a public offering, raising $4 million in gross proceeds. The offering included 3,640,000 shares of common stock and warrants to purchase up to 14,560,000 shares at $1.10 per share and warrant. Proceeds will be used for advancing clinical and preclinical programs.

Revelation Biosciences, Inc. (REVB) plans to use the funds for key initiatives such as completing ongoing Phase 1b clinical trial, manufacturing clinical drug supplies, conducting preclinical studies for multiple indications, developing new products, and supporting general corporate operations. Roth Capital Partners served as the sole placement agent for the transaction.

Investors are urged to consider AI stocks with greater growth potential and limited downside risk. A report suggests looking into a promising AI stock with 100x upside potential. For more investment options, check out the “10 Best Cancer Stocks to Invest in for Long-Term Gains” and “10 Most Oversold Stocks to Buy According to Billionaires” articles. No disclosure was made.



Read more at Yahoo Finance: Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering